Stagecoach Group (SAGKF) Rating Increased to Buy at Zacks Investment Research

Stagecoach Group (OTCMKTS:SAGKF) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research note issued to investors on Friday. The brokerage presently has a $2.00 price objective on the stock. Zacks Investment Research‘s price target would indicate a potential upside of 11.11% from the stock’s current price.

According to Zacks, “Stagecoach Group plc provides passenger transport. It offers bus, coach, train and tram services. The company operates primarily in UK, Europe and North America. Stagecoach Group plc is headquartered in Perth, the United Kingdom. “

How to Become a New Pot Stock Millionaire

OTCMKTS:SAGKF opened at $1.80 on Friday. Stagecoach Group has a 12 month low of $1.80 and a 12 month high of $2.73. The company has a market capitalization of $1,032.02, a price-to-earnings ratio of 5.63, a P/E/G ratio of 1.61 and a beta of 0.80.

TRADEMARK VIOLATION NOTICE: This piece of content was published by Ticker Report and is owned by of Ticker Report. If you are reading this piece of content on another site, it was stolen and reposted in violation of U.S. & international trademark & copyright legislation. The legal version of this piece of content can be viewed at https://www.tickerreport.com/banking-finance/3334554/stagecoach-group-sagkf-rating-increased-to-buy-at-zacks-investment-research.html.

About Stagecoach Group

Stagecoach Group plc, together with its subsidiaries, provides public transportation services in the United Kingdom, mainland Europe, the United States, and Canada. It operates through four segments: UK Bus (Regional Operations), UK Bus (London), North America, and UK Rail. The company offers bus, coach, train, and tram services.

Get a free copy of the Zacks research report on Stagecoach Group (SAGKF)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Stagecoach Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stagecoach Group and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Analyzing Express Scripts  and CVS Health
Analyzing Express Scripts and CVS Health
Reviewing Orix  & PHH
Reviewing Orix & PHH
Synergy Pharmaceuticals  Expected to Post Earnings of -$0.16 Per Share
Synergy Pharmaceuticals Expected to Post Earnings of -$0.16 Per Share
Comparing Cellect Biotechnology  and Its Peers
Comparing Cellect Biotechnology and Its Peers
Analysts Anticipate New Century Bancorp, Inc.   to Post $0.17 EPS
Analysts Anticipate New Century Bancorp, Inc. to Post $0.17 EPS
Contrasting Woori Bank  & Its Peers
Contrasting Woori Bank & Its Peers


Leave a Reply

© 2006-2018 Ticker Report. Google+.